Cargando…
A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of misdiagnos...
Autores principales: | Chen, Zhongjian, Yang, Chenxi, Guo, Zhenying, Song, Siyu, Gao, Yun, Wang, Ding, Mao, Weimin, Liu, Junping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600931/ https://www.ncbi.nlm.nih.gov/pubmed/34789172 http://dx.doi.org/10.1186/s12885-021-08980-5 |
Ejemplares similares
-
Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
por: Li, Na, et al.
Publicado: (2021) -
Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
por: Gao, Yun, et al.
Publicado: (2022) -
Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
por: Guo, Zhenying, et al.
Publicado: (2021) -
Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma
por: Xu, Xiaoling, et al.
Publicado: (2020) -
GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma
por: Wang, Ding, et al.
Publicado: (2023)